




Health State Utilities for Economic Evaluation of Bariatric Surgery: A Comprehensive 
Systematic Review and Meta-Analysis 
Abstract 
Health-state utilities (HSUs) are health economic metrics that capture and assess health-related 
quality of life (HRQoL). They are essential in health-economic evaluations when calculating 
quality-adjusted life years. We investigated published studies reporting bariatric surgery-
related HSUs elicited through direct or indirect (multi-attribute utility instrument [MAUI]) 
patient-reported methods (PROSPERO registration number: CRD42019131725). Mean HSUs 
for different time points and HSU changes over time (where feasible) were meta-analysed using 
random-effects models. Of the 950 potentially relevant identified studies, n=28 (2004-2018) 
qualified for data extraction, with n=85 unique HSUs elicited mainly from the EQ-5D (88%). 
Most (75%) studies were published after 2013. The follow-up duration varied between studies 
and was often limited to 12 months. The pooled mean HSU was 0.72 (0.67–0.76) at 
baseline/pre-surgery (n=18) and 0.84 (0.79–0.89) one-year post-surgery (n=11), indicating a 
0.11 (0.09-0.14) utility unit increment. EQ-5D showed the similar results. This positive 
difference can be partially explained by BMI and/or co-morbidities status improvement. This 
study provides a valuable summary of HSUs to future bariatric surgery-related cost-utility 
models. However, more well-designed higher-quality bariatric-related HSU studies are 
expected for future reviews to improve the available evidence. We suggest that researchers 





Abbreviations: 15D, 15-dimensional questionnaire; % EBMIL, percentage excess BMI loss; 
AGB, adjustable gastric banding; AQoL-8D, Assessment of Quality of Life 8-dimension; 
ASMBS, American Society for Metabolic and Bariatric Surgery; BMI, body mass index; 
CHEERS, Consolidated Health Economic Evaluation Reporting Standards; CI, confidence 
interval; CUA, cost-utility analysis; CVD, cardiovascular disease; EQ-5D, EuroQoL five-
dimensions scale; MA-II, Moorehead-Ardelt II questionnaire; MAUI, multi-attribute utility 
instrument; HRQoL, health-related quality of life; HSUs, Health-state utilities; HUI, Health 
Utilities Index; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-
Analyses; QALY, quality-adjusted life year; QWB, Quality of Well-Being Scale; RYGB, 
Roux-en-Y gastric bypass; SD, standard deviation; SF-6D, Short Form-6-dimension; SG, 
sleeve gastrectomy; T2DM, type 2 diabetes mellitus; TTO, time trade-off; WMD, weighted 
mean difference. 
1. INTRODUCTION 
1.1 Obesity and bariatric surgery 
Obesity (defined as body mass index [BMI] ≥30 kg/m2) is epidemic worldwide.1 Based on the 
World Health Organization’s most recent data, 13% of adults worldwide were obese.2 
Moreover, the proportion of people with severe (BMI ≥35 kg/m2) and morbid (BMI ≥40 kg/m2) 
obesity is rising at a faster rate than obesity.3-5 Obesity poses significant health risks (including 
physical and psychosocial co-morbidities and premature death) to the lives of affected patients, 
particularly for people who are morbidly obese.6,7 Beyond health risks, obesity has also been 
consistently shown to negatively impact health-related quality of life (HRQoL).8 Moreover, 
obesity imposes substantial economic burden from individual, health payer and societal 
perspectives for developed and developing countries due to, for example, direct healthcare 





Efficacious interventions to prevent or treat obesity are urgently needed to minimise the 
adverse HRQoL and direct and indirect cost consequences associated with this condition. An 
efficient healthcare system needs to offer cost-effective treatments for all diseases including 
obesity because of healthcare resource scarcity.11 Based on the analysis of substantial primary 
data, we previously found that bariatric (weight loss, metabolic) surgery is a cost-saving 
treatment for patients with obesity over the lifetime.12,13 Besides, bariatric surgery has been 
reported to be the only clinically effective and sustainable approach to severe and resistant 
obesity.14,15 In addition to actual weight loss and the possible resolution of obesity-related co-
morbidities following surgery, another widely recognised important outcome measure is the 
HRQoL improvement. 
1.2 Health-state utilities (HSUs) and associated measures 
Cost-utility analysis (CUA), a type of cost-effectiveness analysis, has become increasingly 
popular in assisting the decision-making process in several countries, particularly for 
government reimbursement decisions.16-18 In CUA, the cost effectiveness (or even cost savings) 
of an intervention is expressed in terms of the incremental cost per quality-adjusted life year 
(QALY), where the QALY combines increased life expectancy (quantity of life) and 
improvements in health status (quality of life).19 QALY is a potentially useful measure of 
outcome for decision-making processes and enable direct comparisons to be made between 
treatment alternatives across various conditions. In order to generate QALYs, preference-based 
HRQoL weights (also known as HSUs) are combined with the length of time spent in the health 
states of interest.20 
HSUs are scored between ‘0’ representing death and ‘1’ representing perfect health, and 
negative values represent health states deemed to be worse than death.21 Methods for measuring 





measurement asks the person to value directly their own health under conditions of uncertainty 
by using a valuation technique such as time trade-off (TTO) or standard gamble methods.23 
Indirect measurement involves the use of multi-attribute utility instruments (MAUIs) such as 
the European EuroQoL five-dimensions scale (EQ-5D; http://www.euroqol.org), the Canadian 
Health Utilities Index (HUI; http://www.healthutilities.com), the UK Short Form-6-dimension 
(SF-6D; http://www.shef.ac.uk/scharr/sections/heds/mvh/sf-6d), the Finnish 15-dimensional 
questionnaire (15D; http://www.15d-instrument.net/15d), the US Quality of Well-Being Scale 
(QWB; https://eprovide.mapi-trust.org/instruments/quality-of-well-being-scale) and the 
Australian Assessment of Quality of Life 8-dimension (AQoL-8D; http://www.aqol.com.au), 
where patients complete the instrument’s array of questions on their current health state and 
these responses are scored using a value set obtained from the general population.24,25 With a 
burgeoning literature of HSUs, which values should be used as inputs in a model is becoming 
a challenging task. As these MAUIs are far from identical in terms of their descriptive system 
and covered health states, the choice of MAUI may affect the estimated HSUs, and in turn the 
CUA outcomes.26 Supplement 1 provides a detailed comparison of the characteristics of these 
instruments. QWB is the first reported MAUI which was released in 1976 in the US, and the 
AQoL-8D is the most recently developed MAUI targeting both physical and psychosocial 
health dimensions. The EQ-5D dominates the economic evaluation literature (up to 63% of all 
MAUIs), as expected from the recommendations of the National Institute for Health and Care 
Excellence (NICE) guidelines to use the EQ-5D as the preferred measure of HRQoL in adults.27 
1.3 Bariatric surgery-related HRQoL and research gaps 
A number of structured or systematic reviews have shown that the HRQoL of patients suffering 
from obesity improved after surgery.28-33 However, these studies are mainly comprised of 
disease-specific (e.g., Moorehead-Ardelt II questionnaire [MA-II]) or non-preference-based 





not generate a utility value. An emerging literature has shown that HSUs have been used as a 
metric for quantifying HRQoL improvements regarding bariatric surgery,34-61 nevertheless, 
meta-analyses of bariatric surgery-related HSUs have not been conducted to date. This is 
surprising, especially given the large number of routinely conducted economic evaluations of 
bariatric surgeries.62-68 Consequently, these modelling studies have not been able to benefit 
from the meta-analytical HSU estimates, and most rely on the same source of HSUs, with 
variation in HSU assumptions across models.65,69-71 HSUs from  single study may not always 
be a reliable indicator of underlying HRQoL, particularly, where HSUs is not the main focus 
of the research. Meta-analyses, on the other hand, have the advantage of combining all 
published HSUs for a given population to maximize the generalizability and representativeness 
of the estimates used in any economic model, as well as providing insight into the factors that 
influence HRQoL.21 
1.4 Objectives of our systematic review 
We acknowledge the current debate regarding HSUs generated by differing MAUIs 
predominantly because of their descriptive systems, nevertheless, no previous studies have 
comprehensively investigated and meta-analysed HSU evidence regarding bariatric surgery. 
Therefore, to address this important research gap, this comprehensive systematic review and 
meta-analysis aims to generate a database of HSUs that could be used to populate future model-
based cost-utility analyses of bariatric surgery procedures. The study as such has two main 
aims: 
1) to undertake a systematic overview of published studies reporting HSU-based HRQoL 





2) to obtain bariatric surgery-related pooled HSUs (from baseline [pre-surgery] to various 
post-surgery time points) and HSU changes over time (where feasible) that can be used 
to adjust life expectancy in future CUA. 
2. METHODS 
The protocol of this systematic review was registered on 17 May 2019 at PROSPERO 
(registration number: CRD42019131725; https://www.crd.york.ac.uk/Prospero/). The search 
strategy, data screening, extracting and synthesising were followed by the protocol. 
2.1 Validated guidelines 
This systematic review was performed in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement72 and the Campbell and 
Cochrane Economics Methods Group guidelines.73 
2.2 Literature search 
Based on previous recommendations74-76 and systematic reviews77,78 in the field, the literature 
search was conducted from inception until September 2019 in three biomedical databases 
(PubMed, EMBASE via OVID and Scopus) and three economic databases (American 
Economic Association [EconLit], the Cost-Effectiveness Analysis [CEA] Registry, and the 
Centre for Reviews and Dissemination [CRD], which includes the Database of Abstracts of 
Reviews of Effects [DARE], Health Technology Assessment Database [HTA] and National 
Health Service Economic Evaluation Database [NHS EED]). 
To ensure literature search saturation, a keyword search of Google Scholar, hand searches and 
citation tracking of all selected articles and relevant reviews were performed. 
The search strategies were developed in consultation with a research librarian at the University 





we identified relevant free-text terms by referring to the published recommendations74,76,79 and 
recent analogous systematic reviews77,80. The search strategy combined terms for direct and 
indirect methods of HSUs elicitations with terms for bariatric surgery. We initially kept the 
scope and identification of the evidence for HSUs broad. Supplement 2 outlines the initial 
search strategy for EMBASE via OVID database, which was also adapted for both biomedical 
and economic databases. Economic filters were considered when searching for evidence on 
generalist databases, such as PubMed. A simplified search was undertaken without using 
economic filters for evidence on economics databases such as EconLit. 
Search results were exported to the Covidence online program (Veritas Health Innovation, 
Melbourne, Australia; https://www.covidence.org), and duplicate articles were removed before 
screening. Screening of eligible studies was conducted in three steps: first, titles and abstracts 
were screened by two co-authors (QX and JC) for evidence relevant to HSUs related to bariatric 
surgery; second, the two co-authors independently assessed the full-text of the remaining 
studies based on the inclusion criteria of qualitative analysis; third, shortlisted articles with 
requisite HSU data were further considered for data extraction/synthesis for the meta-analysis. 
Two additional co-authors (AP and HA) were consulted for a final decision in case of any 
discrepancies. The number of records identified, retrieved, screened, assessed, included, and 
excluded in the review, and reasons for exclusions, is summarized in a PRISMA flow diagram 
(Figure 1). Referencing was managed in EndNote X8.2 (Thomson Reuters). 
2.3 Study eligibility 
Studies were considered eligible if: 1) included participants (BMI ≥30 kg/m2) undergoing any 
type of bariatric surgery with assessment of HSUs as primary or secondary patient-reported 





HSUs elicitation methods; and 3) published as full text (with no time restrictions) in English, 
German, Chinese, French and Italian languages. 
Systematic reviews, meta-analyses, conference abstracts, editorials, letters as well as case 
reports were excluded. Studies that obtained HSU estimates from previously published 
literature other than patient-reported outcomes through research or those reporting simulation-
based utilities were also excluded. If articles referred to the same study population and reported 
multiple HSUs estimates, the article with the most comprehensive data or the most relevant 
HSU measures were retained for data syntheses. Where the required HSU data for meta-
analytical synthesis were missing, corresponding authors were contacted to improve the 
comprehensiveness of our study’s meta-analyses. If the HSU data could not be provided, the 
study was excluded from the meta-analysis but still retained in the systematic review. 
2.4 Data extraction 
In order to foster the accuracy of data extraction, a preliminary data collection form was used 
to extract data from 10% of studies. Adjustments and improvements were made to the initial 
form. The first author (QX) used the improved data form to extract data independently, and 
then the co-author (JC) performed cross-checking. Discrepancies were resolved by consensus, 
and if agreement was not reached, two additional reviewers (AP and HA) were consulted to 
reach an agreement. Reviewers were not blinded to information about the authors, author 
affiliation, and journal name, because this has been shown to be unnecessary.81 If HSUs had to 
be read from a graph, the figures were extracted using the plot digitizing tool -WebPlotDigitizer 
(Version 4.2).82 
The data extraction was performed according to the requirements of the Cochrane Handbook 





The following information was extracted from primary studies: first author’s name, year of 
publication, study location, study design of questionnaire assessment (retrospective or 
prospective), surgery type, comparison (e.g., before versus after, surgical versus non-surgical), 
target population, participants’ sociodemographic characteristics (e.g., female proportion and 
mean age) at baseline, HSU elicitation method, modes of questionnaire administration (self- or 
interviewer-administered), types of value set used (local or foreign), sample size, reasons for 
participant dropout of the study, BMI and obesity-related co-morbidities in each observational 
time-point, number of follow-ups, follow-up durations (short-term follow-up was defined as 
from 1 year to 3 year according to the American Society for Metabolic and Bariatric Surgery 
[ASMBS] outcome reporting standards)83, and HSUs in each observational time-point (mean 
and standard deviation [SD]). Where possible, the individual dimension scores or the 
proportions of individual dimension responses to each MAUI were extracted to identify the 
health aspects that were most impacted by bariatric surgery. In addition, the predictors for HSU 
changes (because of bariatric surgery) were also extracted from the primary studies. 
Where HSU data were available only by respondent subgroups based on patient characteristics 
(e.g., sex), a weighted average of the change score and the score’s precision estimate with 
weights proportional to the subgroup’s size were obtained.73 When this subgrouping was based 
on the alternative elicitation methods as described above (i.e., the type of direct-report) or the 
type of bariatric surgery, then each subgroup was considered independently. 
2.5 Statistical methods for meta-analysis 
We performed a meta-analysis to estimate a single HSU for each time point (i.e., baseline [pre-
surgery] and follow-up [post-surgery] time points). Additionally, statistical meta-analyses to 





surgery] and after [one-year post-surgery] bariatric surgery were also performed in the form of 
forest plots. 
All statistical analyses and graphing were carried out in STATA (STATA 15.1, StataCorp, 
College Station, Texas, USA). The command “metan” was used to conduct meta-analysis.84 
Random-effects models were used because of the variable nature of the source populations for 
each study to accommodate for likely between-study heterogeneity.85 
Additional variability in meta-analysis estimates may stem from inter-MAUI differences 
related to instrument scales, instrument descriptive/classification systems and the sophisticated 
algorithms that derive the HSUs. Therefore, to examine the nature of these potential sources of 
heterogeneity, subgroup analyses regarding different elicitation methods were performed. 
Subgroup analyses for WMD before and after bariatric surgery were only estimated for studies 
using the EQ-5D instrument, owing to the small number of included studies using other 
instruments. Additionally, potential heterogeneity based on different surgery types and gender 
groups was also examined. 
Formal quality assessment of primary studies eliciting utility values was not undertaken, given 
a lack of standard systems or checklists for grading the quality of such studies.74,76 
Consequently, we examined potential publication and small study bias, visually, using funnel 
plots (where a symmetrical plot suggested no or little bias) and using Egger’s regression 
asymmetry test (where a p-value of <0.1 indicated a statistically significant difference). 
Sensitivity analyses were undertaken to evaluate the stability of the meta-analysis results. 
Individual studies were excluded from all meta-analyses sequentially to gauge the influence of 
individual studies on the overall results (by using STATA “metaninf” command).86 When the 







3.1 Eligible studies 
Figure 1 presents the process of study selection based on PRISMA methodology. The search 
strategy yielded 950 citations, with 889 (94%) citations from biomedical databases, 55 (6%) 
from economic databases and six (<1%) from other sources. After removing duplicates 676 
potentially relevant publications remained for title and abstract screening, with 137 studies 
included for full-text review. Of these, n=28 studies were included in the qualitative synthesis. 
We subsequently excluded 12 more studies as they either fully or partially relied on the same 
data sample,34,46,54,58,59,61 or did not report requisite HSU data.36,40,48,49,51,56 Consequently, only 
16 studies were eligible for the meta-analysis.35,37-39,41-45,47,50,52,53,55,57,60 
3.2 Study characteristics of the qualitative synthesis (n=28) 
Overall, the 28 included studies reported a total of 85 unique HSUs related to bariatric surgery. 
Supplement 3 provides summary characteristics of the included studies, while all reported 
HSUs were summarised in Supplement 4. The first study regarding HSUs of bariatric surgery 
was published in 2004,34 and most articles (n=21; 75%) were published after 2013 (Figure 2) 
which is consistent with the increased popularity of health economic evaluations of bariatric 
surgery in recent years. Only a small fraction of these studies (n=5; 18%) was published in 
health economics journals,37,41,54,55,59 and the vast majority (n=23; 82%) in general medical 
journals. 
Of the included studies, half (n=14, 50%) were conducted in Europe (Finland [n=2], Spain 
[n=2], Netherlands [n=2], UK [n=2], Sweden [n=3], France [n=1] and Multicentre within 
Europe [n=2]), 28% from North America (n=8: US [n=4] and Canada [n=4]), 11% (n=3) from 





the distribution of health economic evaluations of bariatric surgery worldwide.12,13 Notably, no 
study was conducted in developing countries. 
Roux-en-Y gastric bypass (RYGB), adjustable gastric banding (AGB) and sleeve gastrectomy 
(SG) were the three most prevalent procedures, with RYGB and AGB predominantly reported 
in earlier years, and SG in later years, and also reflecting the technical change of bariatric 
surgery.13,87,88 
Study designs included: retrospective studies (n=8, 29%) and prospective studies (n=20, 71%). 
Across the twenty-eight identified studies, the baseline sample sizes varied between 23 and 893 
(Mean: 194). The dropout was only occurred and was subsequently reported in n=9 studies, 
with n=4 studies also providing the reasons for dropout (Supplement 3). 
Whilst most HSU estimates were available for multiple follow-up times (between 2 and 60 
months), the follow-up duration varied between studies and was often limited to up-to 12 
months (short-term follow-up). Synthesis of HSUs in each observational time point was shown 
in Section 3.3. 
The mean age in many (23 out of 28, 82%) included studies ranged between 40 and 50 years. 
As to sex distribution, all studies except one reported a largely female dominance (average 
female proportion: 76%). Of the 26 studies that provided clear evidence regarding the BMI 
categories of obesity and associated co-morbidities, n=17 (65%) focused on patients with 
morbid obesity. The mean BMI at baseline was 45.65 (44.13, 47.16) kg/m2. On average, the 
BMI decreased by 13.81 kg/m2 (95% CI: 11.02–16.59) one-year post-surgery.  Similarly, most 
studies (n=17) reported the improvements in co-morbidities’ status of patients with obesity as 
a result of surgery, with T2DM and cardiovascular disease (CVD, mainly hypertension in this 





In 63% of cases, HSU estimates for bariatric surgery were based on self-administered surveys, 
whereas 30% were based on interview-administered surveys. All HSU estimates were obtained 
indirectly using MAUIs, and no directly estimated HSUs were identified (Supplement 4). Of 
the 85 recorded HSUs, n=75 (88%) were measured using the EQ-5D suite of instruments and 
the associated value set for the particular country (3L: n=66; 5L: n=6). The remaining HSUs 
were based on the 15D (n=4; 5%), AQoL-8D (n=4; 5%), and SF-6D (n=2; 2%). Most HSU 
estimates (n=64, 75%) were elicited using the local population norms. HSUs were elicited 
using a single MAUI in most studies: 21 studies used the EQ-5D and two studies the 15D 
MAUI. In addition, there were five studies that used multiple MAUIs: three used the EQ-5D 
and AQoL-8D; and two used EQ-5D and SF-6D. 
3.3 Impact of bariatric surgery on HSUs (n=16) 
Tables 1 and 2 present the overall as well as subgroup pooled mean HSU estimates at baseline 
and different follow-up durations. The pooled mean HSU estimate was 0.72 (0.67-0.76), 0.81 
(0.77-0.85) and 0.84 (0.79-0.89) units at baseline, six-month and one-year post-surgery, 
respectively (Table 1, Figure 3 [A] and [B]). HSUs captured by SF-6D and AQoL-8D were 
significantly lower than those from the EQ-5D suite of instruments and 15D (Table 1). 
However, the SF-6D, AQoL-8D and 15D-based HSUs in this comparison were only supported 
by single studies (Table 1). HSUs were similar among different surgery types (Table 2). Pooled 
results based on gender difference were not estimated due to insufficient data (Supplement 4). 
Overall, the HSU estimate increased a 0.11 [0.09, 0.14] utility unit one-year post-surgery 
(Figure 3 [C]). Similar results were identified for the EQ-5D suite of instruments. On average, 
the EQ-5D HSU increased by 0.13 (0.09, 0.17) utility units one-year after bariatric surgery 





As shown in two studies,44,47 patients’ HSU improved more for the surgical group than the non-
surgical group (Supplement 4), however, the combined data could not be further pooled and 
then analysed due to varying follow-up durations.  
3.4 Impact of bariatric surgery on individual health dimensions 
Five studies reported the proportion of individual dimension responses to the EQ-5D suite of 
instruments. As shown in Table 3, patients presented at baseline with more HRQoL impacts 
for the health dimensions of mobility, usual activities and pain/discomfort, and not a large 
impact on self-care. Improvements in the distribution of responses were recorded one-year 
post-surgery in four out of the five EQ-5D dimensions (i.e., mobility, usual activities, 
pain/discomfort and anxiety/depression), especially for mobility and usual activities.  
Scores for the individual dimensions of the 15D (baseline vs. one-year) were available in one 
study.39 At baseline, larger HRQoL impacts were reported in respiratory, sexuality and usual 
acts, and improvements were also recorded in these dimensions one-year after surgery 
(Supplement 5 [A]).  
The AQoL-8D’s individual dimensional scores were available in only one study for baseline 
versus one-year comparison.55 At baseline, HRQoL impacts were larger in the psychosocial 
dimensions of health (e.g., mental health and happiness) compared to those in the physical 
dimensions of health (e.g., independent living and pain). The improvements were recorded in 
all dimensions especially for psychosocial dimensions (Supplement 5 [B]). 
3.5 Predictors of HSU changes due to bariatric surgery 
As shown in Supplement 6, eleven studies investigated the potential predictors of change in 





methods including correlations analysis and multiple regression models. All but one study 
investigated the relationship of weight/BMI reduction with change in HSUs due to bariatric 
surgery, with six recording a significant association. Baseline utility was reported as a 
significant predictor in one study only. No other significant predictors of HSUs change were 
identified in these studies.   
3.6 Publication bias and sensitivity analysis 
There was no evidence of publication bias based on Egger’s test for HSU at one-year post-
surgery (z= -1.36, P=0.18) and HSU changes before versus after one-year surgery (z= -0.37, 
P=0.71). Significant publication bias was found in baseline HSUs (z= -2.14, P=0.03). The trim-
and-fill analysis was conducted, but no studies were imputed. After removing one study (the 
orange marker in Supplement 7 [A]) with extreme HSU data, publication bias was no longer 
evident (P=0.185) and the mean baseline HSU stabilized (0.727 [0.681, 0.773]). Funnel plots 
are shown in Supplement 7. Test of influence of an individual study on the overall meta-
analysis estimate did not show significant outliers. 
4. DISCUSSION 
Our comprehensive study is the first to systematically summarise and meta-analyse HSUs 
regarding bariatric surgery treatment for obesity. Our research substantially overcomes the 
challenges associated with systematically selecting utility data for economic evaluations of 
bariatric surgery. The meta-analytical estimates that we have generated can be used as inputs 
to future bariatric surgery-related cost-utility models. We found that HSU estimates before and 
after bariatric surgery were largely elicited through the EQ-5D MAUIs. Limited studies used 
the SF-6D, AQoL-8D and 15D MAUIs, and no study used direct methods. A significant 





postoperative year. We also found that the reporting of HSUs for bariatric surgery reflected the 
surgical technical change of bariatric surgery globally,13 whilst more reporting is called for in 
proportion to the large number of bariatric surgery-related models. 
All studies included in our comprehensive systematic review supported bariatric surgery as an 
effective option in improving HRQoL for people with obesity. We found a mean HSU 
difference of +0.11 units between the baseline and one-year after bariatric surgery (+0.13 units 
for EQ-5D), and this difference exceeds the minimal clinically important difference for all the 
MAUIs reported in previous studies (from +0.04 units [EQ-5D] to +0.08 units [AQoL-
8D]).54,55,89-91 In conjunction with this positive HSU difference (from baseline to one-year after 
bariatric surgery), our study also observed a substantial decrease in the mean BMI. Six out of 
ten studies reported an inverse relationship between weight/BMI and HSU post-surgery. The 
findings are in line with a systematic review of reviews that found a significant negative 
association between obesity and HRQoL, and that the relationship between weight loss and 
improved HRQoL was consistently demonstrated after bariatric surgery.92 Besides, metabolic 
co-morbidities are reported to be associated with impaired HRQoL among patients who 
suffered from obesity, and the improvement of these conditions could improve patients’ 
physical and psychosocial quality of life.93 Accompanied with the reported weight loss, our 
study also observed an improvement of co-morbidities’ status (e.g., T2DM and CVD) in most 
of the primary studies.34,38,42,43,46 However, most studies did not independently consider the 
impact of co-morbidities on HSUs. Future studies should examine the impact of changes in co-
morbidities status as a result of bariatric surgery on the HSU/HRQoL for patients with 
obesity.94 
According to the newest population norms for the EQ‑5D‑3L for 20 countries, HSUs for the 
general populations (with healthy body weight) ranged from 0.74 to 0.95.95 Whilst for patients 





using a TTO score.96 In our present study, similar HSU result was identified for people with 
obesity before undergoing surgery (0.72 [0.67-0.76]); however, an extraordinary higher HSU 
of 0.84 was reported in a longitudinal survey for waitlist patients through 15D MAUI.39,97 
Considering the baseline characteristics of these patients (waitlisted, morbidly obese, 83% 
comorbidities affected)39,97, we suggest that the key reason for the higher HSU could be due to 
the relatively young age group (42.1±10.6 years) considered in this study; otherwise, the use  
of the 15D MAUI for a waitlisted population’s HSUs needs further investigation because HSUs 
from the other four included studies that investigated patients waiting for bariatric surgery 
ranged from 0.51 to 0.70 (three from EQ-5D and one from AQoL-8D).42,47,54,55 
As confirmed by previous studies, heterogeneity among studies may stem from various sources 
including the differences between various MAUIs due to their different instrument scales, 
descriptive systems and utility formula.26 The choice of the utility assessment method can  have 
a considerable effect on the predicted HSUs and, hence, on the outcome of economic 
evaluation.98,99 For instance, in the present meta-analysis, we found that HSUs captured by the 
SF-6D and AQoL-8D were significantly lower than those from the EQ-5D and 15D (in 
particular) (Table 1). Our results should however be interpreted with some caution as being 
derived from a subgroup meta-analysis based on a limited number of studies (i.e., n=2 for 
AQoL-8D,54,55 n=1 for SF-6D37 and n=2 for 15D34,39). 
Whilst the EQ-5D was the most commonly used MAUI to estimate HSUs, there is a debate as 
to whether the EQ-5D’s descriptive system can capture and assess all the relevant domains of 
health for people who are waiting for and subsequently undergo bariatric surgery. Our study’s 
findings suggest that the AQoL-8D preferentially captured the psychosocial domains of health 
compared to the EQ-5D. Moreover, our pooled findings are important because a recent 
publication in the Journal of the American Medical Association emphasised the importance of 





emphasis on mental health directly translates to the notion of choosing a MAUI that is 
preferentially sensitive to the relevant domains of health for the particular study population. 
We note that the AQoL-8D MAUI was specifically developed to achieve an increased 
sensitivity for capturing and assessing the complex physical and psychosocial HRQoL health 
states that are relatively neglected in other MAUIs, particularly for people with complex and 
chronic disease states.101,102 However, as identified by our present study, only two HSU studies 
using the AQoL-8D MAUI longitudinally have been published to date. We therefore hope that 
the use of AQoL-8D or other MAUIs that are sensitive to the relevant domains of health for 
people with bariatric surgery, may provide more credible HSUs. 
In addition to the elicitation method, other potential sources of variation in reported HSU values 
may include patients’ socio-demographic characteristics (e.g., age, sex or initial BMI), surgery 
type, follow-up durations, mode of administration and co-morbidities status. However, these 
may not have a large impact on our meta-analyses results as patient-level HSUs were only 
considered in our study, and patients’ socio-demographic characteristics in our study (i.e., sex 
proportion, mean age and mean BMI) were generally comparable across included studies 
(Supplement 8). Through additional subgroup meta-analysis (Table 2), we further established 
that surgery type did not contribute to this variation. Meta-regression was not possible for all 
variables due to the insufficient number of included studies. Future studies are recommended 
to investigate the magnitude of effect and relative contribution of each of the pertinent impact 
factors on HSUs of people who receive bariatric surgery. 
Our study has unique strengths. This is the first study to systematically assess and summarise 
HSUs related to bariatric surgery, which provides a standard set of HSUs that could be used in 
health economic assessments of bariatric surgery procedures. An advantage of undertaking a 
meta-analysis is that it provides both an average value as well as extreme values that could be 





particularly important as there is considerable heterogeneity in the HSUs between bariatric 
surgery studies. Likewise, a further strength of our study is the broad range of study populations 
conducted in, for example, different countries and ethnicities, maximising the generalizability 
and representativeness of the HSU estimates used in bariatric surgery-related economic models. 
This systematic review and meta-analyses also has limitations. First, our meta-analytical HSU 
estimates predominantly relied on the EQ-5D MAUIs with limited coverage of psychosocial 
health aspects, and potential ceiling and floor effects. Second, HSU follow-up times were 
generally limited to short term (up to one year), hence, our study failed to capture longer-term 
changes in HSUs as a result of bariatric surgery. The long-term data from this study should be 
interpreted with some caution when using in the models. Third, HSU differences between 
surgical and non-surgical groups were not available in current meta-analysis due to the lack of 
relevant data. Fourth, we have used mean with SD in data syntheses. The distribution of the 
HSU values was not reported in most of the primary studies, sometimes these values can be 
negatively skewed which may bias the pooled HSU estimates downwards. Fifth, recall biases 
could not be neglected from few studies due to the observational nature. Finally, quality 
appraisal of the included studies was not undertaken in the current study, given a lack of 
standard systems or checklists for grading the quality of HSU studies; nevertheless, our study 
is the first gold-standard systematic review and meta-analysis that provides a baseline of studies 
to date. 
Summary of recommendations for future HSU analyses: 
•  A preferentially sensitive MAUI should be selected that appropriately captures and 
measures both the complex and interdependent physical and psychosocial health needs 





• Before versus after comparisons, to some extent, underestimated the impairment of 
obesity on HRQoL due to the fact that this study design does not consider the effect of 
follow-up on patients with obesity who do not receive bariatric surgery. To avoid it, 
future studies should consider simultaneous control group to balance the time effect 
among patients with and without surgery; 
• Studies with longer time horizons are needed to assess the long-term effects of bariatric 
surgery on utility based HRQoL; 
• Future studies also need to test and report the distribution of HSU data to improve the 
reporting quality; 
• Future studies that examine the HRQoL impact of changes in obesity-associated co-
morbidities status (as well as other potential factors such as complications and 
revisional procedures) as a result of surgery are also needed; 
• More HSU research from developing countries are needed. For example, obesity 
prevalence is increasing, and obesity surgery is also prevalent in China; however, 
relative to population health economic evaluation is less reported, and despite the 
inclusion criteria of various languages including Chinese this study did not capture any 
HSU estimates from China or other similar countries; 
• Guidelines or structured recommendations are urgently needed to support authors and 
reviewers in assessing their study quality. 
5. CONCLUSIONS 
This study represents the first systematic review and meta-analysis of HSUs regarding bariatric 
surgery treatment for obesity, demonstrating the relative lack of published HSU-based HRQoL 
for bariatric surgery. We have seen the increasing trend of health economic evaluations of 
bariatric surgery since 2013. Meta-analysis results suggest that HSU-based quality of life 





explained by BMI and/or co-morbidities status improvement. The meta-analytical estimates 
that we have generated can be used as more reliable inputs to future bariatric surgery-related 
cost-utility models.  However, more well-designed higher-quality bariatric-related HSU studies 
are expected for future reviews to improve the available evidence, including longer follow-up 
times.103  
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